Billionaire's Institute Donates $90 Million to Stanford Patch.com Just recently, Weissman and his colleagues reported in the journal Science that this protein works particularly well when used in combination with other known anti-cancer agents, such as rituximab (a lymphoma drug) and trastuzumab, also known as ... |
